Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/24/2025

Evaluation and Management of Normal Pressure Hydrocephalus and Associated Conditions

Initial Assessment and Management

  • The European Urology guidelines recommend performing immediate bladder ultrasound to measure post-void residual volume, with urinary retention with volumes >300-500 mL requiring urgent catheterization 1, 2
  • Acute urinary retention in elderly men is most commonly caused by benign prostatic hyperplasia (BPH) with bladder outlet obstruction, occurring at a rate of 34.7 episodes per 1,000 patient-years in men aged 70+ 3
  • The American Geriatrics Society recommends documenting a basic falls evaluation including assessment of potentially reversible causes such as medications, environmental factors, balance disorders, visual deficits, and cognitive impairment 4
  • If the patient exhibits the classic NPH triad (gait disturbance, urinary incontinence/retention, and cognitive impairment), urgent neurology referral for brain imaging is indicated 2

Medication Management

  • The American Geriatrics Society recommends reviewing all current medications for drugs that worsen urinary retention: anticholinergics, alpha-adrenergic agonists, and opioids 4, 2, 6
  • Antimuscarinics are potentially inappropriate in elderly patients with urinary retention risk, chronic constipation, or cognitive impairment 6
  • Do not prescribe antimuscarinics without first measuring post-void residual, as men with elevated baseline PVR are at risk for acute urinary retention 2, 6

Urologic Referral and Follow-Up

  • Recurrent or refractory urinary retention despite medical therapy requires immediate urologic referral 3
  • The European Urology guidelines recommend reassessing at 2-4 weeks after initiating alpha-blocker therapy to evaluate symptom response using the International Prostate Symptom Score (IPSS) and assess tolerability 2, 3
  • Combination therapy with 5-alpha-reductase inhibitor (finasteride 5 mg daily) and tamsulosin reduces overall BPH progression risk by 67% and acute urinary retention risk by 79% compared to monotherapy 3

Common Pitfalls to Avoid

  • Do not delay urologic referral in elderly patients with severe obstruction - the risk of complications increases dramatically with age 3
  • Do not add tadalafil to alpha-blockers - this combination shows no additional benefit and carries higher adverse event risk 2, 6
  • Do not assume breathing difficulty is purely respiratory - severe urinary retention causes significant distress that can manifest as dyspnea 1
  • Do not overlook the possibility of NPH when gait instability and urinary symptoms coexist, especially if cognitive changes are present 4

REFERENCES

2

Management of Frequent Urination in Older Adults [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Treatment of Severe BPH with Bladder Outlet Obstruction in Elderly Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

First-Line Medication for Urinary Incontinence in Elderly Men [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025